"Thyrotoxicosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
| Descriptor ID |
D013971
|
| MeSH Number(s) |
C19.874.397.685
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thyrotoxicosis".
Below are MeSH descriptors whose meaning is more specific than "Thyrotoxicosis".
This graph shows the total number of publications written about "Thyrotoxicosis" by people in this website by year, and whether "Thyrotoxicosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 4 | 0 | 4 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Thyrotoxicosis" by people in Profiles.
-
Recurrent Graves' disease post SARS-CoV-2 infection. BMJ Case Rep. 2021 Aug 06; 14(8).
-
Low serum TSH in the acute phase of COVID-19 pneumonia: thyrotoxicosis or a face of "non-thyroidal illness syndrome"? Clin Chem Lab Med. 2021 10 26; 59(11):e420-e423.
-
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study. Endocrine. 2021 08; 73(2):255-260.
-
Letter to the Editor: Thyroiditis and Thyrotoxicosis After the SARS-CoV-2 mRNA Vaccine. Thyroid. 2021 09; 31(9):1440.
-
Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19. J Clin Endocrinol Metab. 2021 01 23; 106(2):e926-e935.
-
Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020 Oct; 183(4):381-387.
-
Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management. Ann Endocrinol (Paris). 2020 Oct; 81(5):507-510.
-
Approach to the Patient With Thyrotoxicosis Using Telemedicine. J Clin Endocrinol Metab. 2020 08 01; 105(8).
-
SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. 2020 Aug; 43(8):1171-1172.
-
An Unusual Case of Decompensated Heart Failure in a Young Man. Clin Chem. 2019 01; 65(1):51-54.